ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
VistaGen Reports Positive New Data from AV-101, Probenecid Study
September 07, 2020VistaGen Therapeutics announced positive new data from the Company's second preclinical study of its oral investigational drug, AV-101, in combination with probenecid. Probenecid has extensive data supporting its safe oral delivery and ability to ... -
VistaGen, Baylor Announce Successful Results of AV-101 for Suicidal Ideation in Vets
December 20, 2019VistaGen Therapeutics and Baylor College of Medicine announced successful results from a first-step, Phase 1b clinical study with healthy U.S. military Veterans ...
Pharma Sources Insight January 2025
